___

• 1. World Health Organization. International drug monitoring: the role of the hospital. Geneva: The Organization, 1966.
• 2. Mirakian R, Ewan PW, Durham SR, Youlten LJ, Dugué P, Friedmann PS et al. BSACI guidelines for the management of drug allergy. Clin Exp Allergy 2009; 39: 43-61.
• 3. Lange L, Koningsbruggen SV, Rietschel E. Questionnaire-based survey of lifetime-prevalence and character of allergic drug
• reactions in German children. Pediatr Allergy Immunol. 2008 Nov;19(7):634-8.
• 4. Orhan F, Karakas T, Cakir M, Akkol N, Bahat E, Sonmez FM, et al. Parental-reported drug allergy in 6- to 9-yr-old urban schoolchildren. Pediatr Allergy Immunol. 2008 Feb;19(1):82- 5.
• 5. Kaya A, Erkoçoğlu M, Civelek E, Çakır B, Kocabaş CN. Prevalence of confirmed IgE-mediated food allergy among adolescents
• in Turkey. Pediatr Allergy Immunol. 2013 Aug;24(5):456-62.
• 6. Kvedariene V, Sitkauskiene B, Tamasauskiene L, Rudzeviciene O ,Kasiulevicius V, Nekrosyte G, et al. Prevalence of selfreported
• drug hypersensitivity reactions among Lithuanian children and adults. Allergol Immunopathol (Madr). 2019 Jan - Feb;47(1):32-37.
• 7. Arikoglu T, Aslan G, Batmaz SB, Eskandari G, Helvaci I, Kuyucu S. Diagnostic evaluation and risk factors for drug allergies
• in children: from clinical history to skin and challenge tests. Int J Clin Pharm. 2015 Aug;37(4):583-91.
• 8. Tan VA, Gerez IF, Van Bever HP. Prevalence of drug allergy in Singaporean children. Singapore Med J. 2009 Dec;50(12):1158-61.
• 9. Davies DM, Ashton CH, Rao JG, Rawlins MD, Routledge PA, Savage RL et al. Comprehensive clinical drug information service: first year’s experience. Br Med J 1977;1:89–90.
• 10. Thong BY, Leong KP, Tang CY, Chng HH. Drug allergy in a general hospital: Results of a novel prospective inpatient reporting system. Ann Allergy Asthma Immunol 2003;90:342-7.
• 11. Demoly P, Adkinson NF, Brockow K, Castells M, Chiriac AM, Greenberger PA et al. International consensus on drug allergy. Allergy 2014 Apr;69(4):420-37.
• 12. Bircher AJ, Scherer Hofmeier K. Drug hypersensitivity reactions: Inconsistency in the use of the classification of immediate
• and nonimmediate reactions. J Allergy Clin Immunol 2012;129: 263–64
• 13. Romano A, Torres MJ, Castells M, Sanz ML, Blanca M. Diagnosis and management of drug hypersensitivity reactions. J Allergy Clin Immunol. 2011 Mar;127:67-73
• 14. Adkinson NF. Drug Allergy. Adkinson NF, YungingerJW, BusseWW, Bochner BS Holgate ST, Simons FE (eds) Middleton's
• Allergy: Principles and Practice 6. baskı Mosby, China, 2003, s: 1679-1694.
• 15. Pichler WJ. Delayed drug hypersensitivity reactions. Ann Intern Med 2003;139:683–693.
• 16. Türkiye Ulusal Allerji ve Klinik İmmünoloji Derneği. Çelik G, Dursun B (eds). İlaç aşırı duyarlılık reaksiyonlarına yaklaşım ulusal rehber güncellemesi 2019. Buluş Tasarım, Ankara, 2019.
• 17. Adkinson NF Jr. Risk factors for drug allergy. J Allergy Clin İmmunol 1984;74:567
• 18. Demoly P, Viola M, Rebelo Gomes E, Romano A. Epidemiology and causes of drug hypersensitivity. In: Pichler EJ (ed). Drug hypersensitivity, Karger Basel, Switzerland 2007.
• 19. Celik GE, Pichler WJ, Adkinson NF. Drug allergy. In: Adkinson NF, Bochner BS, Wesley Burks A, Busse WW, Holgate ST,
• Lemanske RF, O’Hehir ER (eds). 8th ed. Middleton's Allergy Principles and Practice. Elsevier Saunders. 2014:1274-95.
• 20. Carr A, Swanson C, Penny R, Cooper DA. Clinical and laboratory markers of hypersensitivity to trimethoprim-sulfamethoxazole
• in patients with Pneumocystis carinii pneumonia and AIDS.J Infect Dis. 1993 Jan;167(1):180-5.
• 21. Gomes ER, Kuyucu S. Epidemiology and risk factors in drug hypersensitivity reactions. Curr Treat Options Allergy 2017;4:239-57.
• 22. Cornejo-García JA, Guéant-Rodriguez RM, Torres MJ, Blanca- Lopez N, Tramoy D, Romano A, et al. Biological and genetic
• determinants of atopy are predictors of immediate-type allergy to betalactams, in Spain. Allergy. 2012 Sep;67(9):1181-5.
• 23. Blanca-López N, Cornejo-García JA, Pérez-Alzate D, Pérez- Sánchez N, Plaza-Serón MC, Doña I, et al. Hypersensitivity
• Reactions to Nonsteroidal Anti-inflammatory Drugs in Children and Adolescents: Selective Reactions. J Investig Allergol Clin Immunol. 2015;25(6):385-95
• 24. Pichler WJ, Adam J, Daubner B, Gentinetta T, Keller M, Yerly D. Drug hypersensitivity reactions: Pathomechanism and clinical symptoms. Med Clin N Am 2010;94:645-64.
• 25. Pichler WJ. Immun mechanism of drug hypersensitivity. Immunol Clin North Am 2004;373-97.
• 26. Schnyder B. Approach to the patient with drug allergy. Immu¬nol Allergy Clin North Am 2009; 29: 405-18.
• 27. Demoly P, Lebel B, Messaad D, Sahla H, Rongier M, Daures JP. Predictive capacity of histamine release for the diagnosis of drug allergy. Allergy 1999;54:500-6.
• 28. Brockow K, Romano A, Blanca M, Ring J, Pichler W, Demoly P. General considerations for skin test procedures in the diagnosis of drug hypersensitivity. Allergy 2002; 57: 45-51.
• 29. Naisbitt DJ, Farrell J, Wong G, Depta JP, Dodd CC, Hopkins JE, et al. Characterization of drug-specific T cells in lamotrigine
• hypersensitivity.J Allergy Clin Immunol. 2003 Jun;111(6):1393-403.
• 30. Naisbitt DJ, Britschgi M, Wong G, Farrell J, Depta JP, Chadwick DW, et al. Hypersensitivity reactions to carbamazepine:
• characterization of the specificity, phenotype, and cytokine profile of drug-specific T cell clones. Mol Pharmacol. 2003 Mar;63(3):732-41.
• 31. Brockow K, Romano A. Skin tests in the diagnosis of drug hypersensitivity reactions. Curr Pharm Des. 2008;14(27):2778-91.
• 32. Lezmi G, Alrowaishdi F, Bados-Albiero A, Scheinmann P, de Blic J, Ponvert C. Non-immediate-reading skin tests and prolonged
• challenges in non-immediate hypersensitivity to betalactams in children. Pediatr Allergy Immunol. 2018 Feb;29(1):84-89
• 33. Romano A, Blanca M, Torres MJ, et al. ENDA; EAACI. Diagnosis of nonimmediate reactions to beta-lactam antibiotics. Allergy 2004; 59: 1153-60.
• 34. Tonson la Tour A, Michelet M, Eigenmann PA, Caubet JC. Natural History of Benign Nonimmediate Allergy to Beta-Lactams
• in Children: A Prospective Study in Retreated Patients After a Positive and a Negative Provocation Test. J Allergy Clin Immunol Pract. 2018 Jul - Aug;6(4):1321-1326.
• 35. Joint Task Force on Practice Parameters; American Academy of Allergy, Asthma and Immunology; American College of Allergy,
• Asthma and Immunology; Joint Council of Allergy, Asthma and Immunology. Drug allergy: an updated practice